Is Sinopharm Group Co., Ltd. a good investment? Sinopharm Group Co., Ltd. (1099.HK) is currently trading at 20.92 HKD. Market analysts have a consensus price target of 22.79 HKD. This suggests a potential upside from current levels.
In terms of valuation, the stock trades at a P/E ratio of 7.82. This relatively low multiple may signal that Sinopharm Group Co., Ltd. is undervalued compared to historical market norms.
Earnings Schedule: Sinopharm Group Co., Ltd. is expected to release its next earnings report on April 23, 2026. The market consensus estimate for Forward EPS is 3.06.
For income investors, Sinopharm Group Co., Ltd. pays a dividend yield of 3.49%. With a payout ratio of 71%, the dividend appears sustainable.
Yes, it pays an annual dividend of 0.65 HKD (3.49% yield).
Sinopharm Group Co., Ltd. is classified as a Stock. You can compare it against 2 other assets in the "Related Symbols" list on this page.
The next earnings date is projected to be April 23, 2026. The company currently has a trailing EPS of 2.60.
Sinopharm Group Co. Ltd., together with its subsidiaries, engages in the wholesale and retail of pharmaceutical and healthcare products, and medical devices in the People's Republic of China. The company operates through four segments: Pharmaceutical Distribution, Medical Devices Distribution, Retail Pharmacy, and Other Business. The Pharmaceutical Distribution segment distributes pharmaceutical products to hospitals, other distributors, retail pharmacy stores, and clinics. This segment also offers distribution, logistics, and other value-added services for domestic and international pharmaceutical and healthcare products manufacturers, and other suppliers. The Medical Devices Distribution segment distributes medical devices, as well as provides installation and maintenance services. The Retail Pharmacy segment operates and franchises a network of retail drug stores. The Other Business segment engages in the distribution of laboratory supplies; manufacture and distribution of chemical reagents; and production and sale of pharmaceutical products. The company rents and manages properties; distributes medical instruments and equipment, Chinese herbal medicines, antibiotics, and biological products; and offers information technology, investment, goods and technology import and export, business consulting, health consultation, medical consulting, market information consulting and investigation, and convention and exhibition services. It also manages medical project investment, consulting, and technology training activities; and manufactures medicines. The company was founded in 2003 and is headquartered in Shanghai, the People's Republic of China. Sinopharm Group Co. Ltd. is a subsidiary of Sinopharm Industrial Investment Co., Ltd.
3.49% (5y avg: 4.33%)
0.65 HKD
June 23, 2026
71.41%
| Year | Total Dividends |
|---|---|
| 2026 | 0.78 HKD |
| Aug. 18, 2026 | 0.7829 |
| 2025 | 0.74 HKD |
| Aug. 12, 2025 | 0.7390 |
| 2024 | 0.96 HKD |
| Aug. 13, 2024 | 0.9560 |
| 2023 | 0.90 HKD |
| Aug. 14, 2023 | 0.9011 |
| 2022 | 0.87 HKD |
| Aug. 23, 2022 | 0.8720 |
| 2021 | 0.84 HKD |
| Aug. 10, 2021 | 0.8394 |
| 2020 | 0.65 HKD |
| Aug. 11, 2020 | 0.6522 |
| 2019 | 0.67 HKD |
| Aug. 27, 2019 | 0.6712 |
| 2018 | 0.69 HKD |
| Aug. 28, 2018 | 0.6868 |
| 2017 | 0.57 HKD |
| Aug. 31, 2017 | 0.5721 |
| 2016 | 0.48 HKD |
| Aug. 16, 2016 | 0.4824 |
| 2015 | 0.31 HKD |
| July 31, 2015 | 0.3100 |
| 2014 | 0.26 HKD |
| July 25, 2014 | 0.2600 |
| 2013 | 0.25 HKD |
| July 12, 2013 | 0.2500 |
| 2012 | 0.19 HKD |
| July 20, 2012 | 0.1900 |
| 2011 | 0.16 HKD |
| July 20, 2011 | 0.1600 |
| 2010 | 0.01 HKD |
| July 20, 2010 | 0.0101 |
Yearly aggregated dividends
|
Sinopharm Group Co., Ltd.
Aug 18, 2026 Upcoming
Dividend
0.78287 HKD |
|
Sinopharm Group Co., Ltd.
Aug 12, 2025 Paid
Dividend
0.739 HKD |
Unlock detailed news and exclusive insights with our Premium subscription.
See Pricing Plans
Community Discussion